The state of Alabama currently has 17 active clinical trials seeking participants for Multiple Sclerosis research studies. These trials are conducted in various cities, including Birmingham, Mobile, Huntsville and Anniston.
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Recruiting
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofatumumab versus staying on their continued current therapy. This study will also look at whether an elevated serum neurofilament light (NfL) level predicts enhanced benefit from a switch to ofatumumab.
Gender:
All
Ages:
Between 18 years and 50 years
Trial Updated:
02/01/2024
Locations: Novartis Investigative Site, Birmingham, Alabama +1 locations
Conditions: Relapsing-Remitting Multiple Sclerosis
Effects of Chiropractic Care on Cytokine Levels in Multiple Sclerosis
Recruiting
Multiple sclerosis (MS) is an inflammatory autoimmune disease associated with an imbalance between pro- and anti-inflammatory markers (cytokines) resulting in a demyelinating and neurodegenerative disease. There is early evidence that spinal manipulation (chiropractic care) is better than control in influencing immune (cytokine) activity in asymptomatic participants, but few studies have been completed in participants with chronic inflammatory conditions, such as MS. The purpose of this project... Read More
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
12/20/2023
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Multiple Sclerosis, Relapsing-Remitting
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
Recruiting
The primary objective of this study is to measure the concentration and the regional brain distribution of activated brain microglia/macrophages using the PET radiopharmaceutical [F-18]DPA-714 in individuals with chronic pain and fatigue suspected to be associated with neuroinflammation. The PET tracer [F-18]DPA-714 binds to the 18 kDa translocator protein (TSPO, also known as the peripheral benzodiazepine receptor) in the mitochondria of activated microglia/macrophages and provides a non-invasi... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
12/12/2023
Locations: University of Alabama at Birmingham Medical Center, Birmingham, Alabama
Conditions: Fibromyalgia, Chronic Fatigue Syndrome, Multiple Sclerosis, Healthy
AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
Recruiting
The UAB Institute for Arts In Medicine (AIM) is currently implementing an expressive emotional writing pilot project for adults with paralysis caused by neurological conditions such as traumatic head or spinal cord injury.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/27/2023
Locations: 354 School of Health Professions Building, Birmingham, Alabama
Conditions: Spinal Cord Injuries, Multiple Sclerosis, Transverse Myelitis, Amyotrophic Lateral Sclerosis
ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program
Recruiting
The investigators have previously shown that youth with MS are very inactive, and that vigorous physical activity is associated with higher levels of well-being and lower MS disease activity in youth. Yet, no effective physical activity interventions have been developed for youth with MS to date. The investigators have taken input from youth with MS to create a Smartphone-based app (the ATOMIC - Active Teens with Multiple Sclerosis - App) that provides tailored physical activity information and... Read More
Gender:
All
Ages:
Between 11 years and 21 years
Trial Updated:
03/15/2022
Locations: The University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Pediatric Multiple Sclerosis